Business Courier features incoming UC Lindner dean
Marianne Lewis discusses her passion for business in Q&A
Marianne Lewis doesn't officially take the reins of the Carl H. Lindner College of Business until July 1, but the Cincinnati Business Courier wasn't about to wait until then to learn more about the University of Cincinnati's newest dean.
In a May 16 Q&A with the Courier's Andy Brownfield, Lewis discussed her background, the transformation of Cincinnati, her love of travel and her belief that business can be a force for good.
"I think about the way digitalization is changing our world, and people talk about it in doomsday scenarios," said Lewis. "Business has always had that potential just because it is powerful, but you can flip it on the other side and see the potential for conscious capitalism and the idea of how you help business be about social transformation and not just economic transformation."
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.